Groups | No. | Period | TSH (mIU/L) | TT3 (µg/L) | TT4 (µg/L) | FT3 (pmol/L) | FT4 (pmol/L) |
Rivastigmine | 25 | Before treatment | 4.0 ± 0.9 | 1.6 ± 0.3 | 76.1 ± 10.7 | 5.8 ± 2.1 | 18.0 ± 3.5 |
25 | After 12 weeks | 4.0 ± 0.9 | 1.7 ± 0.2 | 74.6 ± 9.3 | 5.7 ± 1.7 | 17.7 ± 2.9 | |
25 | After 24 weeks | 4.2 ± 0.8 | 1.7 ± 0.3 | 76.6 ± 8.1 | 5.6 ± 1.8 | 17.9 ± 2.9 | |
Rivastigmine plus RSC | 27 | Before treatment | 4.1 ± 0.9 | 1.7 ± 0.3 | 78.2 ± 10.7 | 6.0 ± 1.3 | 17.8 ± 3.7 |
27 | After 12 weeks | 4.1 ± 1.0 | 1.7 ± 0.3 | 79.2 ± 9.6 | 5.7 ± 1.3 | 18.1 ± 3.2 | |
27 | After 24 weeks | 4.2 ± 0.9 | 1.6 ± 0.2 | 78.0 ± 9.7 | 6.1 ± 1.3 | 16.9 ± 3.3 |